Varvaro Thomas C

CIK 00014374952 companiesGLEN ELLYN, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001437495

Recent Transactions

37 trades

Exercise/Conversion
MABVAX THERAPEUTICS HOLDINGS, INC.
Restricted Stock Unit
2018-04-03−513→ 0 total
Exercise/Conversion
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2018-04-03+513→ 23,063 total
Award
MABVAX THERAPEUTICS HOLDINGS, INC.
Option to Purchase Common Stock
2018-02-21+35,000→ 35,000 total
Sale
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2018-01-24$0.84/sh−17,996→ 67,645 total
Sale
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2018-01-23$0.87/sh−17,445→ 85,641 total
Award
MABVAX THERAPEUTICS HOLDINGS, INC.
Restricted Stock Unit
2017-10-02+75,790→ 75,790 total
Award
MABVAX THERAPEUTICS HOLDINGS, INC.
Restricted Stock Unit
2017-09-15+24,210→ 24,210 total
Award
MABVAX THERAPEUTICS HOLDINGS, INC.
Option to Purchase Common Stock
2017-06-12$1.57/sh+20,000→ 20,000 total
Award
MABVAX THERAPEUTICS HOLDINGS, INC.
Option to Purchase Common Stock
2017-05-19$1.80/sh+50,000→ 50,000 total
Exercise/Conversion
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2017-04-02+1,543→ 3,086 total
Exercise/Conversion
MABVAX THERAPEUTICS HOLDINGS, INC.
Restricted Stock Unit
2017-04-02−1,543→ 1,543 total
Award
MABVAX THERAPEUTICS HOLDINGS, INC.
Option to Purchase Common Stock
2017-01-01$3.38/sh+3,800→ 3,800 total
Award
MABVAX THERAPEUTICS HOLDINGS, INC.
Option to Purchase Common Stock
2016-08-29$5.00/sh+3,800→ 3,800 total
Award
Niagen Bioscience, Inc.$NAGE
Employee Stock Options (right to buy)
2016-08-15+70,000→ 70,000 total
Award
MABVAX THERAPEUTICS HOLDINGS, INC.
Option to Purchase Common Stock
2016-06-29$0.55/sh+35,000→ 35,000 total
Exercise/Conversion
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2016-04-04+11,417→ 11,417 total
Exercise/Conversion
MABVAX THERAPEUTICS HOLDINGS, INC.
Restricted Stock Unit
2016-04-04−11,417→ 22,833 total
Award
MABVAX THERAPEUTICS HOLDINGS, INC.
Option to Purchase Common Stock
2015-08-26$1.52/sh+35,000→ 35,000 total
Award
Niagen Bioscience, Inc.$NAGE
Employee Stock Options (right to buy)
2015-07-06+125,000→ 2,154,499 total
Purchase
Niagen Bioscience, Inc.$NAGE
Common Stock
2014-08-25$1.09/sh+2,250→ 507,000 total
Purchase
Niagen Bioscience, Inc.$NAGE
Common Stock
2014-08-22$1.20/sh+1,250→ 504,750 total
Award
Niagen Bioscience, Inc.$NAGE
Common Stock
2014-01-21+250,000→ 503,500 total
Disposition to Issuer
Niagen Bioscience, Inc.$NAGE
Employee Stock Options (right to buy)
2012-12-21−645,900→ 2,032,600 total
Disposition to Issuer
Niagen Bioscience, Inc.$NAGE
Employee Stock Options (right to buy)
2012-12-21−95,712→ 1,290,988 total
Award
Niagen Bioscience, Inc.$NAGE
Employee Stock Options (right to buy)
2012-12-21+863,511→ 2,154,499 total
Disposition to Issuer
Niagen Bioscience, Inc.$NAGE
Employee Stock Options (right to buy)
2012-12-21−645,900→ 1,386,700 total
Award
Niagen Bioscience, Inc.$NAGE
Employee Stock Options (right to buy)
2012-08-28+200,000→ 2,678,500 total
Award
Niagen Bioscience, Inc.$NAGE
Common Stock
2012-07-09+250,000→ 253,500 total
Purchase
Niagen Bioscience, Inc.$NAGE
Common Stock
2011-12-09$0.65/sh+2,000→ 3,500 total
Purchase
Niagen Bioscience, Inc.$NAGE
Common Stock
2011-12-07$0.63/sh+1,500→ 1,500 total
Award
Niagen Bioscience, Inc.$NAGE
Employee Stock Options (right to buy)
2011-05-10+100,000→ 100,000 total
Award
Niagen Bioscience, Inc.$NAGE
Employee Stock Options (right to buy)
2010-05-20−614,250→ 614,250 total
Award
Niagen Bioscience, Inc.$NAGE
Employee Stock Options (right to buy)
2010-05-20−200,000→ 200,000 total
Award
Niagen Bioscience, Inc.$NAGE
Employee Stock Options (right to buy)1
2010-05-20−75,000→ 75,000 total
Award
Niagen Bioscience, Inc.$NAGE
Employee Stock Options (right to buy)
2010-05-20−614,250→ 614,250 total
Award
Niagen Bioscience, Inc.$NAGE
Employee Stock Options (right to buy)
2010-05-20−200,000→ 200,000 total
Award
Niagen Bioscience, Inc.$NAGE
Stock Option (Right to buy)
2009-05-13+75,000→ 75,000 total

Companies

Recent Filings

Address

363 HILLSIDE AVE

GLEN ELLYN, IL, 60137

View on SEC.gov